Metabolic Tagging of Tumour Extracellular Vesicles for Targeted Modulation of Dendritic Cells
Journal of Extracellular Vesicles · 2026-06 · 15 (6)
DOI: 10.1002/jev2.70304 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Extracellular Vesicles, online erschienen am 28.05.2026. Verfasst von Rimsha Bhatta und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Materials Science and Engineering, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA. Hauptthemen laut MEDLINE: Dendritic Cells, Extracellular Vesicles, Neoplasms. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NSF, American Cancer Society.
Abstract (Originalsprache)
Extracellular vesicles (EVs) have emerged as a promising alternative to cell‐based therapies due to their benign safety profiles and favourable pharmacokinetic properties. Tumour EVs, in particular, have shown promise to function as a therapeutic cancer vaccine for various cancer types. However, the efficient and targeted delivery of EVs to dendritic cells, the prominent type of antigen‐presenting cells in the body, remains a challenge. Here we report the metabolic tagging of tumour EVs with azido groups for subsequent conjugation of anti‐DEC205 via efficient click chemistry. We showed that azido‐sugars can metabolically label cancer cells with azido groups and that azido‐labelled cells can secrete azido‐tagged EVs. Anti‐DEC205, upon facile modification with dibenzocyclooctyne, was successfully conjugated onto azido‐tagged EVs. Anti‐DEC205‐conjugated EVs were preferentially internalized by dendritic cells over other types of immune cells, and improved the processing and presentation of EV‐encased antigens by dendritic cells. We further demonstrated the ability of anti‐DEC205‐conjugated EVs to induce enhanced cytotoxic T lymphocyte responses and antitumor efficacy in comparison with control EVs. Our study provides a facile and universal approach to chemically tagging EVs and conjugating targeting moieties to EVs, for targeted modulation of cells of interest.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Materials Science and Engineering, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.
- Department of Bioengineering, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.
- Cancer Center at Illinois (CCIL), Urbana, Illinois, USA.
- Carle College of Medicine, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.
- Beckman Institute for Advanced Science and Technology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.
- Materials Research Laboratory, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.
ORCID-Profile: Hua Wang
Förderung
- NCI NIH HHS
- NSF
- American Cancer Society
- Distinguished Scientise Award from Sontag Foundation
- National Natural Science Foundation of China
- National Cancer Institute
Zitieren
APA
Bhatta, R., Xu, W., Dai, R., Liu, Y., Zhou, J., Xue, Y., & Wang, H. (2026). Metabolic Tagging of Tumour Extracellular Vesicles for Targeted Modulation of Dendritic Cells. Journal of Extracellular Vesicles, 15(6). https://doi.org/10.1002/jev2.70304
Vancouver
Bhatta R, Xu W, Dai R, Liu Y, Zhou J, Xue Y, et al. Metabolic Tagging of Tumour Extracellular Vesicles for Targeted Modulation of Dendritic Cells. Journal of Extracellular Vesicles. 2026;15(6). doi:10.1002/jev2.70304
BibTeX
@article{Bhatta2026,
author = {Bhatta, Rimsha and Xu, Wenhao and Dai, Ruike and Liu, Yusheng and Zhou, Jiadiao and Xue, Yixin and Wang, Hua},
title = {Metabolic Tagging of Tumour Extracellular Vesicles for Targeted Modulation of Dendritic Cells},
journal = {Journal of Extracellular Vesicles},
year = {2026},
volume = {15},
number = {6},
doi = {10.1002/jev2.70304}
}
EUVIMED